1
TITLE: EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin  Full Text
AUTHORS: Samantha Cambier; Richard J Sylvester; Laurence Collette; Paolo Gontero; Maurizio A Brausi; George van Andel; Wim J Kirkels; Fernando Calais Da Silva; Willem Oosterlinck; Stephen Prescott; Ziya Kirkali; Philip H Powell; Theo M de Reijke; Levent Turkeri; Sandra Collette; Jorg Oddens;
PUBLISHED: 2016, SOURCE: EUROPEAN UROLOGY, VOLUME: 69, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
2
TITLE: ADJUVANT FOLFOX4+/- CETUXIMAB IN KRAS WILD-TYPE PATIENTS WITH RESECTED STAGE III COLON CANCER RESULTS FROM THE PETACC8 INTERGROUP TRIAL
AUTHORS: Julien Taieb; Josep Tabernero; Enrico Mini; Fabien Subtil; Gunnar Folprecht; Jean Luc Van Laethem; Josef Thaler; John Bridgewater; Evaristo Sanches; Lone Norgard Petersen; Philippe Rougier; Laurence Collette; Michel Praet; Cecile Girault; Martina Schneider; Pierre Squifflet; Pierre Laurent Puig; Eric Van Cutsem; Laurent Bedenne; Come Lepage;
PUBLISHED: 2012, SOURCE: 14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 23
INDEXED IN: WOS
3
TITLE: Raltitrexed (Tomudex (R)) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)  Full Text
AUTHORS: Ivan Popov; Alfredo Carrato; Alberto Sobrero; Mark Vincent; David Kerr; Roberto Labianca; Angelo Raffaele Bianco; Mostafa El Serafi; Laurent Bedenne; Bernard Paillot; Enrico Mini; Evaristo Sanches; John Welch; Laurence Collette; Michel Praet; Jacques Wils;
PUBLISHED: 2008, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 44, ISSUE: 15
INDEXED IN: Scopus WOS CrossRef